Mental Health Parity Act (MHPAEA) Explained" class="auto-link">mhpaea-mental-health-parity-rights-how-to-invoke-the-federal-parity-law">MHPAEA Mental Health Parity Rights: How to Invoke the Federal Parity Law

Insurance companies have historically applied far more restrictive rules to mental health and substance use disorder (MH/SUD) treatment than to physical health conditions. The Mental Health Parity and Addiction Equity Act (MHPAEA), strengthened by the ACA and 2024 final rules, prohibits this. If your insurer has denied mental health or addiction treatment in ways that would never apply to comparable medical care, you have a powerful federal right to challenge that denial.

What Is MHPAEA?

The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) requires that insurance plans offering mental health and substance use disorder benefits must provide coverage that is no more restrictive than coverage for comparable medical and surgical benefits.

The 2024 final rule (effective for plan years beginning in 2025) significantly strengthened enforcement, requiring insurers to:

• Conduct comparative analyses showing that their treatment limitations on MH/SUD are no more restrictive than limitations on medical/surgical benefits
• Provide those analyses to enrollees, regulators, or their employer upon request
• Demonstrate that any non-quantitative treatment limitation (NQTL) applied to MH/SUD is based on comparable standards as those used for medical/surgical benefits

MHPAEA applies to:

• Most employer health plans (ERISA plans with 50+ employees that offer MH/SUD benefits)
• Health insurance issuers in the individual and group markets
• Medicaid managed care plans
• Children's Health Insurance Program (CHIP)

It does not require plans to offer MH/SUD benefits — but if a plan does offer them, parity applies.

Two Types of Treatment Limitations

MHPAEA regulates two categories of treatment limitations:

Quantitative Treatment Limitations (QTLs): Numerical limits like day limits, visit limits, and dollar caps. Example: A plan cannot limit mental health inpatient stays to 30 days per year if it imposes no similar day limit on medical inpatient stays.

Non-Quantitative Treatment Limitations (NQTLs): Non-numerical restrictions on how benefits are provided. These are harder to identify but far more common. Examples:

• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization requirements (PA required for outpatient mental health but not for comparable medical services)
• Step therapy requirements (requiring patients to try and fail multiple therapies before coverage)
• Geographic limitations (mental health providers only covered in certain areas)
• Fail-first requirements for medications
• Medical necessity criteria that use different standards for MH/SUD than for medical conditions
• Exclusions for certain levels of care (residential treatment, intensive outpatient programs)
• Network composition requirements that result in fewer in-network mental health providers

NQTLs are where most modern parity violations occur, and the 2024 rule substantially increased insurer accountability for NQTLs.

Common Parity Violations

Some of the most common MHPAEA violations seen in practice:

Residential treatment center denials. Many insurers deny residential mental health or substance use treatment as "not medically necessary" using criteria far more restrictive than what would be applied to comparable medical inpatient stays. Courts have found this violates MHPAEA.

Applying PA more broadly to mental health than medical services. If an insurer requires prior authorization for mental health outpatient visits but not for comparable medical outpatient visits (e.g., physical therapy), that is a potential parity violation.

Tiered network structures that exclude MH/SUD. If in-network mental health providers are far scarcer than in-network medical providers, creating effective barriers to care, that may violate network adequacy and parity requirements.

Acute detox without residential coverage. Covering medical detoxification but denying residential rehabilitation, when comparable medical aftercare would be covered, is a common parity violation.

Medication-assisted treatment (MAT) denials. Denying buprenorphine or methadone maintenance treatment using standards that wouldn't apply to medications for comparable chronic conditions (e.g., diabetes management) is a MHPAEA concern.

How to Invoke MHPAEA in Your Appeal

Step 1: Identify the benefit classification. MHPAEA compares benefits within the same classification: inpatient in-network, inpatient out-of-network, outpatient in-network, outpatient out-of-network, emergency care, and prescription drugs. Your comparison needs to be within the right bucket.

Step 2: Identify the analogous medical/surgical benefit. What medical condition is comparable to yours? Depression and anxiety are chronic conditions — compare to diabetes management or cardiac disease management. Substance use disorder residential treatment compares to medical rehabilitation (e.g., cardiac rehab, stroke rehab, skilled nursing).

Step 3: Request the comparative analysis. Under the 2024 rule, you can request the plan's MHPAEA comparative analysis — the document showing how they applied MH/SUD benefit limits compared to medical/surgical limits. ERISA plan participants can request this from the plan administrator. For insured plans, contact your state insurance department. Submit this request in writing.

Step 4: State the parity violation in your appeal.

Template language:

"This denial appears to violate the Mental Health Parity and Addiction Equity Act (MHPAEA), 29 U.S.C. § 1185a, and the 2024 final rule (89 FR 1210). The plan has applied [prior authorization / medical necessity criteria / coverage exclusion] to [mental health / substance use disorder] services that is more restrictive than the requirements applied to comparable medical/surgical services in the same classification. Specifically, [description of the restriction]. We request that the plan provide its comparative analysis demonstrating parity compliance, and we request that this denial be reversed on parity grounds."

Step 5: File simultaneously with regulators. For ERISA plans: File with the U.S. Department of Labor's Employee Benefits Security Administration (EBSA) at dol.gov/ebsa. For insured plans: File with your state insurance department. Both agencies have dedicated MHPAEA enforcement staff.

The Wit v. United Behavioral Health Decision

The 2019 Wit v. United Behavioral Health decision in the Northern District of California (later partially reversed but with significant portions remanded) found that UBH's medical necessity guidelines for mental health and substance use treatment were more restrictive than generally accepted standards of care — a finding that resonated far beyond that case. The case established that insurers cannot apply coverage criteria for mental health treatment that are systematically more restrictive than evidence-based clinical standards.

If your insurer used proprietary guidelines to deny MH/SUD treatment, research whether those guidelines have been challenged and whether the treatment you need aligns with evidence-based clinical standards such as ASAM (American Society of Addiction Medicine) criteria.

Fight Back With ClaimBack

If your mental health or substance use treatment was denied, ClaimBack helps you draft an appeal that specifically invokes MHPAEA and identifies the parity violation the insurer may have committed.

Start your appeal at ClaimBack

Related Reading

• Internal vs. External Insurance Appeal
• Common Reasons Insurance Claims Are Denied
• What Is Medical Necessity?